Jessica Weidman is Associate Director of Global Site Agreements within Merck & Co.’s Global Clinical Trial Operations (GCTO) organization. Specifically, Jessica is the lead for North America (USA and Canada) Clinical Trial Research Agreements, both in late and early stage development. In addition, Jessica is the subject matter expert (SME) on institution policy/site form reviews within Global Site Agreements, GCTO. Jessica focuses on reducing cycle times by ensuring there are limited delays in contract execution due to legal language hold ups. Jessica has worked with Merck & Co. for 10+ years, 4 years fully embedded at the company through a CRO and 6 years as a Merck & Co. employee. Jessica received a B.A. in 2008 from Tulane University and a J.D. in 2011 from Pace University School of Law. Jessica is currently pursuing her MPH at Drexel with a major in Global Health and a minor in population health and infectious disease.